Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/31/2003CA2485220A1 Methods for identifying glucose uptake modulators
12/31/2003CA2480892A1 Novel promoter
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670463 Polynucleotides that encode carcinoma proteins or antibodies or immune system cells specific for such proteins.
12/30/2003US6670455 Use of a chromatography separation processes and/or fractional precipitation
12/30/2003US6670453 Crosslinking, agglutination, purification
12/30/2003US6670452 Non-naturally occurring lipoprotein particle
12/30/2003US6670451 Netrins
12/30/2003US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression.
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670446 N1 modified glycopeptides
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670393 Carbamate-based cationic lipids
12/30/2003US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670333 Providing exogenous antiangiogenic protein to endothelial cells associated with said tissue
12/30/2003US6670329 Isolated hybrid polypeptide
12/30/2003US6670328 Inflammatory diseases, xenograft or allograft rejection, asthma
12/30/2003US6670327 bactericidal/ permeability-increasing protein (BPI) protein
12/30/2003US6670326 Depsipeptide compound
12/30/2003US6670325 Treatment of osteocarcinoma with alpha-1—antitrypsin or secretory leucocyte protease inhibitor
12/30/2003US6670324 Cyclic peptide antifungal agents
12/30/2003US6670323 Hemoglobulin mutations for oxygen delivery
12/30/2003US6670183 88kDa tumorigenic growth factor and antagonists
12/30/2003US6670181 Compositions and methods for treating viral infections
12/30/2003US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase
12/30/2003US6670163 Isolated human kinase proteins
12/30/2003US6670162 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/30/2003US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670135 Assaying the binding of a DCSema polypeptide to a VESPR protein.
12/30/2003US6670118 Method for treating papillomavirus infections
12/30/2003US6670114 Screening for molecules which modulate the binding between HCV and human apolipoprotein B
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669960 Contacting drug-containing solution with compressed antisolvent fluid to precipitate drug-containing particles, feed solution including drug in cosolvent system including first and second organic solvents, separating particles
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669939 Peptide mixtures which are mimetics of kaposi sarcoma associated herpes virus (KSHV) proteins, and biological conjugates, used in kits for diagnosis or detection of antibodies or infections of DNA viruses
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003US6669935 Transducing endothelial cells of arteries in brain, with genetic vectors including polynucleotides which code for cytolysis drugs; gene therapy; drug delivery
12/30/2003US6669934 Administering interleukins, cytokines, leukemia inhibitory factors, ciliary neurotrophic growth factors, oncostatins and derivatives to mammals to control pregnancy
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2241923C Receptor-mediated gene transfer system for targeting tumor gene therapy
12/30/2003CA2228389C High buffer-containing enteric coated digestive enzyme bile-acid compositions and method of treating digestive disorders therewith
12/30/2003CA2175971C Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
12/30/2003CA2140927C Platelet aggregation inhibitors
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
12/30/2003CA2093806C Method of treating or preventing type 1 diabetes by oral administration of insulin
12/30/2003CA2090011C Anti-inflammatory factor, method of isolation, and use
12/25/2003WO2003106682A1 Hla-a24-restricted cancer antigen peptide
12/25/2003WO2003105888A1 Acidic insulin preparations with improved stability
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
12/25/2003US20030236255 Immunosuppressive effects of pteridine derivatives
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236242 Viricides
12/25/2003US20030236237 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
12/25/2003US20030236232 Novel spla2 inhibitors
12/25/2003US20030236215 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/25/2003US20030236214 Process is described for the delivery of a therapeutic polynucleotide to a tissue suffering from or potentially suffering from ischemia
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030236208 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides
12/25/2003US20030236206 Diagnosis of disease; screening antibodies
12/25/2003US20030236204 Antisense modulation of histone deacetylase 2 expression
12/25/2003US20030236197 Modulators of beta-amyloid peptide aggregation
12/25/2003US20030236196 Polyoxyethylene glycol-modified tumor necrosis factor for higher concentrations, decreased viscosity, and improved stability; for treatment of inflammation
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030236192 Method of modifying the release profile of sustained release compositions
12/25/2003US20030236191 Agent for preventing and/or treating cachexia
12/25/2003US20030236189 Two synthetic peptides for treatment and prevention of cancers
12/25/2003US20030236188 Troponins; membrane proteins
12/25/2003US20030236187 Uses of lipopolysaccharide binding protein
12/25/2003US20030236186 Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
12/25/2003US20030236185 Novel two Gonadotropin releasing hormones and a method to isolate the same
12/25/2003US20030236184 Novel polynucleotides encoding lamprey GnRH-III
12/25/2003US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
12/25/2003US20030235916 Cationic with cationic surfactant
12/25/2003US20030235915 Human-nucleic acid sequences from breast tumor tissue
12/25/2003US20030235913 Hybrid nucleic acid; screening antibodies
12/25/2003US20030235912 Screening antibodies; cardiovascular disorders; gastrointestinal disorders
12/25/2003US20030235911 Hybrid nucleic acid
12/25/2003US20030235910 Antisense modulation of G protein-coupled receptor 49 expression
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235897 Immunological control of beta-amyloid levels in vivo
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235887 Modulation contraction of stomach tissue; gastrointestinal disorders; applying peptide
12/25/2003US20030235883 Hybrid nucleic acids; cloning; complexing
12/25/2003US20030235880 Genetic engineered nucleic acid
12/25/2003US20030235869 Biological products
1 ... 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 ... 3163